ASHLEY WATSON: Open Payments
NPI 1417241266 · GREENWICH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 14 payments from 7 companies in 2025. Trend: 2023 $269 · 2024 $219 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $97 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| PFIZER INC. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
Products named: MOUNJARO, SHINGRIX, ELIQUIS, Veozah, REXULTI, FARXIGA, TRELEGY ELLIPTA, Wegovy.
Industry payments across NY — which companies pay providers there.
